RE: Bicycle14 Sep 2024 09:42
August 2023
months. The project involves modelling and the use of bioinformatics data in support of target identification for undisclosed Bicycle programs.
Physiomics CEO, Dr Jim Millen, commented: "We are delighted that, having worked on a number of clinical stage projects with Bicycle, we are now complementing these with a substantial project focused on earlier stage drug development.